| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/1756-185X.12515 |
| P698 | PubMed publication ID | 25351815 |
| P50 | author | Sang-Cheol Bae | Q50911059 |
| Chan-Bum Choi | Q79713129 | ||
| P2093 | author name string | Jae-Hoon Kim | |
| Yoon-Kyoung Sung | |||
| Soyoung Won | |||
| Gwan Gyu Song | |||
| P2860 | cites work | Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update | Q22241138 |
| Spotting latent infection: the path to better tuberculosis control | Q24678860 | ||
| Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis | Q27000984 | ||
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial | Q28202166 | ||
| Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial | Q28214774 | ||
| Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 | ||
| Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs | Q33315753 | ||
| Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial | Q33976382 | ||
| Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor | Q34649768 | ||
| An update on the diagnosis of tuberculosis infection | Q36518580 | ||
| Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor | Q36705704 | ||
| Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders | Q37868907 | ||
| Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients | Q39301083 | ||
| Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy | Q40680333 | ||
| Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection | Q44422799 | ||
| Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. | Q44581271 | ||
| Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy | Q44631922 | ||
| Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report | Q45180236 | ||
| [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]. | Q45973789 | ||
| High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy | Q47808177 | ||
| Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. | Q51051059 | ||
| A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. | Q53964227 | ||
| P433 | issue | 3 | |
| P921 | main subject | tuberculin | Q29505 |
| Mycobacterium tuberculosis | Q130971 | ||
| P304 | page(s) | 315-322 | |
| P577 | publication date | 2014-10-28 | |
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents | |
| P478 | volume | 18 |
| Q36301207 | Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis |
| Q40814406 | Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients |
| Q47158308 | Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis |
| Q97556936 | Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis |
Search more.